搜索
CRISPR Therapeutics AG
CRSP添加自选
54.090USD
+1.000+1.88%
收盘 06/18, 16:00（美东）报价延迟15分钟
5.22B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月11日 周一
更新时间: 5月11日 周一
持股股东
股东类型
持股股东
持股股东
占比
ARK Investment Management LLC
11.73%
BlackRock Institutional Trust Company, N.A.
6.92%
Orbis Investment Management Ltd.
6.17%
State Street Investment Management (US)
3.89%
T. Rowe Price Investment Management, Inc.
3.35%
其他
67.95%
持股股东
持股股东
占比
ARK Investment Management LLC
11.73%
BlackRock Institutional Trust Company, N.A.
6.92%
Orbis Investment Management Ltd.
6.17%
State Street Investment Management (US)
3.89%
T. Rowe Price Investment Management, Inc.
3.35%
其他
67.95%
股东类型
持股股东
占比
Investment Advisor
40.10%
Investment Advisor/Hedge Fund
23.67%
Venture Capital
3.37%
Corporation
3.34%
Individual Investor
2.56%
Research Firm
2.41%
Hedge Fund
1.29%
Bank and Trust
0.64%
Sovereign Wealth Fund
0.51%
其他
22.12%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
1020
75.38M
78.16%
-5.90M
2025Q4
980
79.52M
84.90%
+75.16K
2025Q3
1019
79.46M
89.59%
+5.57M
2025Q2
986
73.90M
82.20%
+7.69M
2025Q1
943
66.36M
83.61%
-5.70M
2024Q4
951
66.15M
80.53%
+2.60M
2024Q3
955
62.43M
76.50%
+840.55K
2024Q2
969
61.63M
76.06%
+573.40K
2024Q1
979
61.11M
68.18%
+3.34M
2023Q4
980
54.61M
75.07%
+613.05K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
ARK Investment Management LLC
10.52M
10.96%
+735.08K
+7.51%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.67M
6.95%
+424.08K
+6.79%
Dec 31, 2025
Orbis Investment Management Ltd.
5.95M
6.2%
+968.06K
+19.43%
Dec 31, 2025
State Street Investment Management (US)
3.75M
3.91%
-253.79K
-6.33%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
3.23M
3.36%
-55.99K
-1.71%
Dec 31, 2025
GSK plc
3.22M
3.36%
+3.22M
--
Dec 31, 2025
Geode Capital Management, L.L.C.
2.25M
2.34%
+108.05K
+5.05%
Dec 31, 2025
George (Simeon J.)
1.05M
1.09%
--
--
Mar 15, 2025
SR One Capital Management, LP
2.04M
2.12%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
1.95M
2.04%
+68.29K
+3.62%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ARK Genomic Revolution ETF
10.33%
Global X Genomics & Biotechnology ETF
5.71%
ARK Innovation ETF
5.12%
AXS Green Alpha ETF
4.84%
WisdomTree BioRevolution Fund
2.81%
Virtus LifeSci Biotech Products ETF
2.48%
State Street SPDR S&P Biotech ETF
2.41%
Direxion Daily S&P Biotech Bull 3X Shares
1.48%
Franklin Genomic Advancements ETF
0.92%
ProShares Ultra Nasdaq Biotechnology
0.59%
查看更多
ARK Genomic Revolution ETF
占比10.33%
Global X Genomics & Biotechnology ETF
占比5.71%
ARK Innovation ETF
占比5.12%
AXS Green Alpha ETF
占比4.84%
WisdomTree BioRevolution Fund
占比2.81%
Virtus LifeSci Biotech Products ETF
占比2.48%
State Street SPDR S&P Biotech ETF
占比2.41%
Direxion Daily S&P Biotech Bull 3X Shares
占比1.48%
Franklin Genomic Advancements ETF
占比0.92%
ProShares Ultra Nasdaq Biotechnology
占比0.59%
